The biological role of islet amyloid polypeptide (amylin) in diabetes: some recent results.
作者信息
Sandler S
机构信息
Department of Medical Cell Biology, Uppsala University, Sweden.
出版信息
Diabetologia. 1994 Feb;37(2):225-6.
PMID:8163061
Abstract
摘要
相似文献
1
The biological role of islet amyloid polypeptide (amylin) in diabetes: some recent results.
Diabetologia. 1994 Feb;37(2):225-6.
2
[Amylin/IAPP (islet amyloid polypeptide)--physiology and clinical significance].
Wien Klin Wochenschr. 1997 Jun 6;109(11):379-83.
3
Possible links between amylin and diabetes. Amylin is released into the blood stream along with insulin.
Diabetes Care. 1992 Feb;15(2):297-9. doi: 10.2337/diacare.15.2.297.
4
New treatments of diabetes: the beta-amylin agonists.
Ann Endocrinol (Paris). 2008 Apr;69(2):147-50. doi: 10.1016/j.ando.2008.02.015. Epub 2008 Apr 18.
5
Islet amyloid polypeptide: does it play a pathophysiological role in the development of diabetes?
Diabet Med. 1994 Nov;11(9):825-9. doi: 10.1111/j.1464-5491.1994.tb00363.x.
6
Islet amyloid polypeptide (IAPP) secretion from islet cells and its plasma concentration in patients with non-insulin-dependent diabetes mellitus.
Diabetes Res Clin Pract. 1992 Jan;15(1):89-96. doi: 10.1016/0168-8227(92)90073-z.
7
[Amylin].
Nihon Rinsho. 2002 Jul;60 Suppl 7:517-22.
8
[New pancreatic polypeptide amylin].
Klin Med (Mosk). 1995;73(5):7-11.
9
Basal and stimulated plasma levels of pancreatic amylin indicate its co-secretion with insulin in humans.
Diabetologia. 1991 Jan;34(1):52-4. doi: 10.1007/BF00404025.
10
Role of amylin in insulin secretion and action in humans: antagonist studies across the spectrum of insulin sensitivity.
Diabetes Metab Res Rev. 2002 Mar-Apr;18(2):118-26. doi: 10.1002/dmrr.263.
Zotero 插件